Code of Massachusetts Regulations
105 CMR - DEPARTMENT OF PUBLIC HEALTH
Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements
Section 300.170 - Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by Laboratories
In addition to the requirements of 105 CMR 300.100, 300.171, 300.180(A) and (C), all laboratories, including those outside of Massachusetts performing examinations on any specimens derived from Massachusetts residents that yield evidence of infection due to the organisms listed below, shall report such evidence of infection, including results identified through sequencing methods as specified by the Department, directly to the Department through secure electronic laboratory reporting mechanisms, or other method, as defined by the Department, within 24 hours. A laboratory contact must be included with each report in addition to the test results, source of specimen, date of specimen collection, case's full name, date of birth, sex, race and ethnicity, address, telephone number, and name of the ordering health care provider. Where specified, additional demographic data, clinical data, or epidemiological data may be required. Upon receipt of a laboratory report, the Department shall notify the local board of health in the town in which the case resides within 24 hours via the MAVEN surveillance and case management system.
Anaplasma sp.
Arborviruses including, but not limited to, chikungunya virus, eastern equine encephalitis virus, dengue fever virus, Jamestown Canyon virus, West Nile virus, yellow fever virus, and Zika virus
Babesia sp.
Bacillus anthracis
Bordetella bronchiseptica
Bordetella holmseii
Bordetella parapertussis
Bordetella pertussis
Borrelia burgdorferi
Borrelia miyamotoi
Brucella sp.
Burkholderia mallei
Burkholderia pseudomallei
Campylobacter sp.
Chlamydophila psittaci
Clostridium botulinum
Clostridium difficile
Clostridium perfringens
Clostridium tetani
Corynebacterium diphtheriae
Coxiella burnetii
Cryptosporidium sp.
Cyclospora cayetanensis
Ehrlichia sp.
Entamoeba histolytica
Enteroviruses
Escherichia coli O157:H7
Francisella tularensis
Giardia sp.
Group A streptococcus, from a usually sterile site
Group B streptococcus, from a usually sterile site in children younger than one year old Haemophilus influenzae, from a usually sterile site
Hantavirus
Hemorrhagic fever viruses including, but not limited to, Ebola virus, Marburg virus, and other filoviruses, arenaviruses, bunyaviruses and flaviviruses
Hepatitis A virus
Hepatitis B virus
Hepatitis C virus
Hepatitis D virus
Hepatitis E virus
Evidence of human prion disease
Influenza A and B viruses
Legionella sp.
Listeria sp.
Lymphocytic choriomeningitis virus
Measles virus
Mumps virus
Mycobacterium leprae
Mycobacterium tuberculosis, M. africanum, M. bovis
Neisseria meningitidis, from a usually sterile site
Noroviruses
Novel or unusual coronaviruses causing severe disease
Novel influenza A viruses
Plasmodium sp. including P. falciparum, P. malariae, P. ovale. P. vivax
Poliovirus
Powassan virus
Pox viruses including, but not limited to, variola, vaccinia, and other orthopox and parapox viruses, but excluding molluscum contagiosum viruses
Rabies virus
Rickettsia akari
Rickettsia prowazekii
Rickettsia rickettsii
Rubella virus
Salmonella sp.
SARS-CoV-2
Shiga toxin-producing organisms
Shigella sp.
Simian herpes virus
Streptococcus pneumoniae, from a usually sterile site in individuals younger than 18 years old
Trichinella spiralis
Laboratory evidence of tuberculosis infection
Varicella zoster virus
Vibrio sp.
Yersinia pestis
Yersinia sp.
Evidence of infection due to the organisms listed below shall also be reported directly to the Department through secure electronic laboratory reporting mechanisms, or other method, as defined by the Department, within 24 hours. A laboratory contact must be included with each report in addition to the test results, source of specimen, date of specimen collection, case's full name, date of birth, sex, race and ethnicity, address, telephone number, and name of the ordering health care provider. Where specified, additional demographic data, clinical data, or epidemiological data may be required.
Chlamydia trachomatis
Haemophilus ducreyi
Herpes simplex virus, neonatal infection (in child younger than 60 days old)
Human immunodeficiency virus (HIV)
Klebsiella granulomatis
Neisseria gonorrhoeae
Treponema pallidum
